As IM oxytocin and misoprostol are the most practical options for PPH prophylaxis in low resource settings, the longer shelf life and greater stability of misoprostol [32–35] could make it a preferable option if the two modalities were found to be equivalent [32]. Here, OXT is linked to pulmonary arterial hypertension.